Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
Kaiser Permanente Northern California Division of Research
Oakland, California
Harvard Pilgrim Health Care Institute
Boston, Massachusetts
University of Florida College of Pharmacy
Gainesville, Florida
NEW! NEW!
NEW! NEW!
University of Maryland Medical System
Easton, Maryland
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
NEW! NEW!
Vanderbilt Health
Nashville, Tennessee
NEW! NEW!
NEW! NEW!
NEW! NEW!
Loading... Please wait.
Associate Director, Epidemiology & Evidence Strategy
Who are we? Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair. Acceleron focuses its commercialization, research, and development efforts in hematologic and pulmonary diseases. In hematology, Acceleron and its global collaboration partner, Bristol Myers Squibb, are co-promoting REBLOZYL® (luspatercept-aamt), the first and only approved erythroid maturation agent, in the United States for the treatment of anemia in certain blood disorders. The Companies ar
Loading. Please wait.